Lynx1 Capital Management’s Applied Therapeutics APLT Stock Holding History

Lynx1 Capital Management’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-410,500	Closed	-$41K	–	24
2025 Q4	$41K	Buy	+410,500	New	+$261K	0.01%	22

Lynx1 Capital Management's APLT Position: Q1 2026 in Review

Lynx1 Capital Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 410,500 shares — an estimated $41K sold.

Lynx1 Capital Management first reported a position in APLT in Q4 2025 and held it in 1 quarter. The position peaked at $41K in Q4 2025. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.

Lynx1 Capital Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
Lynx1 Capital Management sold 410,500 Applied Therapeutics shares in Q1 2026, an estimated $41K.
Lynx1 Capital Management first reported a position in Applied Therapeutics in Q4 2025 and held it in 1 quarter.
Lynx1 Capital Management's Applied Therapeutics position peaked at $41K in Q4 2025.
0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.

Based on Lynx1 Capital Management's 13F filing for Q1 2026, filed 4 May 2026.